ECDC advocates for execution of respiratory syncytial virus (RSV) immunization programs including maternal vaccines to protect infants from severe hospitalization.

Study shows high-dose vaccines work better for older adults while cell-based versions benefit younger people as respiratory ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...